Company news
Bio-Techne Corp news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Bio-Techne Releases Second Quarter Fiscal 2021 Results
February 1, 2021
Bio-Techne Announces Strategic Investment In Eminence
January 27, 2021
Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results
January 13, 2021
Bio-Techne Releases First Quarter Fiscal 2021 Results
November 4, 2020
Bio-Techne Announces Commercial Release Of New SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western
October 18, 2020
Bio-Techne Announces ISO 13485: 2016 Certification for the Woburn, MA Manufacturing Facility
October 14, 2020
Bio-Techne To Host Conference Call On November 5, 2020 To Announce First Quarter 2021 Financial Results
October 12, 2020
Bio-Techne Announces Opening Of New Canadian Facility
September 30, 2020
Bio-Techne Announces Grand Opening Of GMP Manufacturing Facility
September 29, 2020
Bio-Techne Announces Publication Of ExoDx Prostate Test Study In Patients With Prior Negative Prostate Biopsy
September 22, 2020
Bio-Techne Announces Commercial Release Of New Co-Detection Assays For Simultaneous Detection Of RNA And Protein On The Same Sample
September 21, 2020
Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The R&D Systems Product Portfolio
September 20, 2020
Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership
September 16, 2020
Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer
September 7, 2020
Bio-Techne Corporation and Leica Biosystems are Accelerating Disease Research with RNAscope™ COVID-19 Probes and the BOND RX*
August 18, 2020
Bio-Techne Announces Release of a New SARS-CoV-1/2 Spike RBD LlaMABody™ Recombinant Antibody that Blocks Viral Entry
August 10, 2020
Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler
August 5, 2020
Bio-Techne Releases Fourth Quarter Fiscal 2020 Results
August 3, 2020
Bio-Techne Announces Appointment Of Julie L. Bushman To Its Board Of Directors
August 2, 2020
Bio-Techne Announces Launch Of ExoCovid-19 Test For Detection Of SARS-CoV-2 In Patient Samples
July 20, 2020
Bio-Techne Announces Commercial Release Of New Assay For Detecting ASOs, miRNAs, And siRNAs In Tissue
July 19, 2020
Bio-Techne To Host Conference Call On August 4, 2020 To Announce Fourth Quarter 2020 Financial Results
July 12, 2020
Bio-Techne Announces Release of GMP ProDots Proteins to Support Cell and Gene Therapy Manufacturing Workflows
June 7, 2020
Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope In Situ Hybridization Detection Kit
May 25, 2020
Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test
May 18, 2020
Bio-Techne Announces Release of GMP Cloudz™ Human T Cell Activation Kit
May 10, 2020
Bio-Techne Announces Publication of ExoDx™ Prostate (IntelliScore) EPI Test Clinical Utility Study
May 6, 2020
Bio-Techne Releases Third Quarter Fiscal 2020 Results
April 29, 2020
Bio-Techne Introduces RePlex Capabilities For Simple Western Assays On Jess™
April 15, 2020
Bio-Techne's Exosome Diagnostics Launches ExoDx Prostate At-Home Collection Kit
April 14, 2020
Bio-Techne To Host Conference Call On April 30, 2020 To Announce Third Quarter 2020 Financial Results
April 7, 2020
Bio-Techne's Ella On The Front Lines In Fight Against COVID-19
March 24, 2020
Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With General Services Administration
March 17, 2020
Bio-Techne Announces Availability Of Next Generation ELISA Kits
February 4, 2020
Bio-Techne Releases Second Quarter Fiscal 2020 Results
February 3, 2020
Bio-Techne Rebrands Atlanta Biologicals Serum And Media As Part Of The R&D Systems Product Portfolio
January 6, 2020
Bio-Techne Licenses aTAG Technology from C4 Therapeutics, Inc.
November 5, 2019
Bio-Techne Releases First Quarter Fiscal 2020 Results
October 28, 2019
Bio-Techne Announces Investment For New GMP Manufacturing Facility
October 27, 2019
Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results
October 7, 2019
Bio-Techne Leverages The RNAscope(TM) Technology To Advance A Multiomic Approach To Antibody Validation
October 6, 2019
Bio-Techne Attains ISO 9001: 2015 Certification for Fetal Bovine Serum Manufacturing Facility
September 15, 2019
Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice(TM) System
August 19, 2019
Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay
August 12, 2019
Bio-Techne Releases Fourth Quarter Fiscal 2019 Results
August 5, 2019
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay
July 22, 2019
Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results
July 17, 2019
Bio-Techne Releases 32x8 Cartridge For The Ella Platform
July 16, 2019
Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues
July 10, 2019
Bio-Techne China Recognized With "Decade of Contribution Award"
June 25, 2019
Calls
The 5 newest of 27 calls. Every call is listed under its year.
- Bio-techne (NASDAQ:TECH) Q3 2026 Earnings Call
May 6, 2026
Transcript - Bio-techne (NASDAQ:TECH) Q2 2026 Earnings Call
Feb 4, 2026
Transcript - Bio-techne (NASDAQ:TECH) Q1 2026 Earnings Call
Nov 5, 2025
Transcript - Bio-techne (NASDAQ:TECH) Q4 2025 Earnings Call
Aug 6, 2025
Transcript - Bio-techne (NASDAQ:TECH) Q3 2025 Earnings Call
May 7, 2025
Transcript
Decks
The 5 newest of 16 decks. Every deck is listed under its year.
- Investor Presentation (January 2026)
Investor deck · 14 slides · January 2026
- Investor Presentation (June 2025)
Investor deck · 15 slides · Jun 3, 2025
- Investor Presentation (January 2025)
Investor deck · 15 slides · Jan 14, 2025
- Investor Presentation (June 2024)
Investor deck · 26 slides · June 2024
- Investor Presentation (January 2024)
Investor deck · 26 slides · January 2024